Edwards Lifesciences stock at USD 86.83 on September 28, 2026
Published on 09/28/2026 at 22:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edwards Lifesciences Corporation shares last traded at USD 86.83 on the NYSE on September 28, 2026, at 20:00:03 UTC. The stock was up 0.63 percent from the previous close of USD 86.29.
Company update
In a September 10, 2026 statement, Edwards Lifesciences commented on the Centers for Medicare & Medicaid Services’ national coverage determination for transcatheter aortic valve replacement. The company said the updated policy supports broader patient access to TAVR and gives Heart Teams greater flexibility in patient evaluation and treatment.
Edwards said implementation and adoption of the policy are expected to take time and that it has confidence in its previously communicated financial guidance for 2026. The company also said it plans to provide 2027 and longer-term guidance at its investor conference in December.
